The 22q11.2 deletion syndrome is caused by non-allelic homologous recombination events during meiosis between low copy repeats (LCR22) termed A, B, C, and D. Most patients have a typical LCR22A-D (AD) deletion of 3 million base pairs (Mb) . In this report, we evaluated IQ scores in 1,478 subjects with 22q11.2DS. The mean of full scale IQ, verbal IQ, and performance IQ scores in our cohort were 72.41 (standard deviation-SD of 13.72), 75.91(SD of 14.46), and 73.01(SD of 13.71), respectively. To investigate whether IQ scores are associated with deletion size, we examined individuals with the 3 Mb, AD (n = 1,353) and nested 1.5 Mb, AB (n = 74) deletions, since they comprised the largest subgroups. We found that full scale IQ was decreased by 6.25 points (p = .002), verbal IQ was decreased by 8.17 points (p = .0002) and performance IQ was decreased by 4.03 points (p = .028) in subjects with the AD versus AB deletion. Thus, individuals with the smaller, 1.5 Mb AB deletion have modestly higher IQ scores than those with the larger, 3 Mb AD deletion.
Overall, the deletion of genes in the AB region largely explains the observed low IQ in the 22q11.2DS population. However, our results also indicate that haploinsufficiency of genes in the LCR22B-D region (BD) exert an additional negative impact on IQ. Furthermore, we did not find evidence of a confounding effect of severe congenital heart disease on IQ scores in our cohort. shown a frequency of 1:992 for deletions of 22q11.2 in low risk pregnancies (Grati et al., 2015) . The syndrome has a frequency of 1:2,000 live births (Cancrini et al., 2014; McDonald-McGinn et al., 2015) . Clinical manifestations of 22q11.2DS are highly heterogeneous and can range from mild to severe. Besides anomalies including congenital heart disease (CHD), palatal abnormalities, renal defects, immunodeficiency, and hypocalcemia, almost all patients with 22q11.2DS have some degree of cognitive impairment. This is in part identified by the presence of reduced IQ scores (Oskarsdottir, Belfrage, Sandstedt, Viggedal, & Uvebrant, 2005; Swillen et al., 1997) . A significant percentage of school age children have learning disabilities requiring placement in special education classes (Bassett et al., 2011; Bearden et al., 2001; De Smedt, Swillen, Ghesquière, Devriendt, & Fryns, 2003; Duijff et al., 2012; Swillen et al., 1997 Swillen et al., , 1999 Woodin et al., 2001 ). Approximately 50% of individuals with 22q112DS have intellectual disability (ID), as defined in part by an IQ score of less than 70 AE 5 , while the rate of ID in the general population is 1-3%. Approximately one-third of 22q11.2DS patients have relatively normal IQ levels within the range of 85 or higher. Overall genetic background can explain some of the ID variability in 22q11DS which was indicated by the cognitive functioning of first-degree relatives (Olszewski, Radoeva, Fremont, Kates, & Antshel, 2014) . While the genetic influence on the variable expression of the cognitive phenotype in 22q11.2DS is still largely unknown, we hypothesized the size or position of the deletion on 22q11.2 may influence IQ scores.
The 22q11.2 deletion occurs due to meiotic non-allelic homologous recombination events between segmental duplications or low copy repeats (LCR22), termed LCR22A, B, C, and D (Edelmann et al., 1999; Shaikh et al., 2000) . The LCR22s do not contain functional genes and are comprised of blocks or modules of high sequence identity (Bailey et al., 2002) . Over 90% of patients have a 3 million base pair (Mb) deletion between LCR22A-D (referred herein as AD).
Approximately 5-8% have a nested, 1.5 Mb, LCR22A-B (AB) deletion, and the rest have deletions of other types (Shaikh et al., 2000) . Consequently, haploinsufficiency of fewer genes in smaller or nested deletions may potentially result in a milder phenotype.
In a recent published study (Evers, Engelen, Houben, Curfs, & van Amelsvoort, 2016) , they did not find a relationship between deletion size and IQ, however, the sample may have been underpowered (63 subjects). In the largest study to date, of 103 subjects with 22q11.2DS, there was also no evidence of a correlation between deletion size and IQ scores, however only four subjects in the study had an AB deletion (Michaelovsky et al., 2012) . As part of the International 22q11.2 Brain and Behavior Consortium (IBBC; Gur et al., 2017; Vorstman et al., 2015) , and prior to its establishment, we collected DNA samples from subjects with 22q11.2DS of age 6 years and older.
We focused on the two most common types of 22q11.2 deletions, the AB (74 subjects) versus AD (1,353 subjects) group. We test whether IQ levels in individuals with AB deletions (No. = 74) would differ from those with AD deletions (No. = 1,353), taking into account possible confounding effects of sex, age, and severe CHD status.
| MATERIALS AND METHODS

| Study population
Recruitment of most of the subjects with 22q11.2DS in this study has been previously described (Gur et al., 2017) . Briefly, a total of >2,000 deidentified DNA samples were collected with their informed consent (Internal Review Board, Committee of Clinical Investigation #1999-201).
All individuals had a clinical diagnosis of 22q11.2DS. Fluorescence in situ hybridization (FISH) was done to make a molecular diagnosis in the majority of subjects, priori to inclusion. In addition, the presence of the deletion was confirmed by array comparative genome hybridization (aCGH) or multiplex ligation-dependent probe amplification (MLPA). It is possible that the presence of severe CHD can influence neuro-cognition and could therefore act as a confounder in the analysis (see below). The majority of subjects had available cardiac phenotype information (Guo et al., 2018) . After removing data with gender mismatch, duplicate or related samples, 1,807 remained for further analysis (Supporting Information Figure S1 ). The 22q11.2DS samples were recruited from 21 study sites, mostly in North America and Europe. We combined the 21 study sites into four groups including USA and Canada, Northern Europe, Southern Europe and UK with Australia (Supporting Information Table S2 ) according both to genetic proximity (not geographical proximity) (Nelis et al., 2009 ) and phenotypic proximity (IQ measure within a group should be more homogeneous than across groups).
| Deletion type detection
Deletion types among 1,807 22q11.2DS patients were identified by copy number variation (CNV) analysis on raw intensity data obtained from Affymetrix 6.0 SNP array CEL files. Briefly, Univariate CNAM optimal segmenting algorithm implemented in Golden Helix SNP&VARIA-TION SUITE version 8.7.2 (http://www.goldenhelix.com/index.html) was employed to detect CNV segment boundaries as determined by log 2 ratio [log 2 (observed intensity/reference intensity)]. In this study, controls included those processed at the same time period and at the same facility as those of the 22q11.2DS samples, and, in addition, we used precomputed intensity data from 270 Hapmap samples. For 1,227 samples, the deletion type was also determined using MLPA (SALSA MLPA kit P250 DiGeorge; MRC Holland, The Netherlands; Vorstman et al., 2006) . Exclusion criteria were deletions that extended further centromeric (proximal) to LCR22A (unbalanced translocations) or deletions that extended further telomeric (distal) to LCR22D, such as LCR22E, F, G, or H. This included the following subjects: LCR22A-G (1 subject, with a frequency of 0.05% among the population), DE (1, 0.01%), DF (1, 0.01%), EF (1, 0.01%), and unbalanced translocation (1, 0.05%). Atypical deletion types that occurred in ≤7 subjects were also excluded in our population, namely/specifically CD (2, 0.1%), nested AB (7, 0.39%), nested AD (4, 0.22%), and proximal PRODH deletions (2, 0.1%). After removing these 20 samples, 1,787 subjects with a recurrent deletion within the AD region were included in this study. Detailed selection steps of patients with 22q11.2DS are shown in Supporting Information Figure S1 . We identified 17 subjects with an atypical, nested 2.8 Mb deletion that occurred just telomeric to the PRODH gene, herein referred to as the (Guo et al., 2018) . This slightly smaller nested deletion type was validated by quantitative PCR analysis using primers in the 22q11.2 breakpoint region (Guo et al., 2018) .
| IQ assessment
There were 1,478 subjects with IQ scores available among the 1,787 subjects in this study. Wechsler Intelligence Scales (e.g., Wechsler Pre- 
| Statistical analysis
All continuous variables including age, full scale IQ, verbal IQ, and performance IQ were expressed as mean AE SD if not specified. Independentsamples t test was employed to evaluate IQ differences between binary variables including gender and presence of severe CHD that could act as a confounder and must be considered. Severe CHD was defined as having a clinically recognized complex cardiac malformation, which usually requires surgery. In this study, it included tetralogy of Fallot (TOF), persistent truncus arteriosus (PTA), or interrupted aortic arch type B (IAAB).
Controls for severe CHD had 22q11.2DS but no detectable heart or aortic arch defect. Association between IQ and deletion size (AD versus AB) was assessed by multiple linear regression analyses with adjustment of sex and age of administration of the IQ test and research site group.
Pearson chi-square test was used to assess the association between CHD status and deletion size. The one-sample Kolmogorov-Smirnov test was used to test whether age was normally distributed among patients with the AB and AD deletion, respectively. Independent-samples MannWhitney U test was employed to compare the age distribution between the AB and AD groups. Median Test, which is also a non-parametric statistical approach, was employed to compare age medians between the two groups. Significance was considered as p < .05.
| RESULTS
| Characterization of the 22q11.2DS study population
Basic demographic characteristics of the population are presented in Table 1 . Among the 1,478 subjects, gender is almost evenly distributed with 709 (48%) males and 769 (52%) females. The subjects were largely Caucasian, and retrospectively enrolled at 21 different research sites (Supporting Information Table S2 ). The ethnicity of our cohort has been previously reported (Guo et al., 2017) . We recently identified an atypical nested A + -D deletion in which the proximal deletion breakpoint was distal to the PRODH gene (Guo et al., 2018) . Similar IQ score distributions were observed between A + -D and AD groups (Supporting Information Figure S2 ), nevertheless, we did not include the 17 A + -D samples in this study of IQ. A total of 307 (20.8%) had severe CHD, while 637 (43.1%) had a normal heart and/or aortic arch. We found that 1,353 (91.5%) had an AD deletion, 74 (5%) had an AB deletion, 27 (1.8%) had an AC deletion, and 7 (0.5%) had a BD deletion. Figure 1D ), which is consistent with previous reports of smaller sized cohorts (Hooper et al., 2013; Niarchou et al., 2014). 3.3 | IQ score distribution among demographic variables in the cohort of subjects with 22q11.2DS
The AD and AB deletion type groups had the largest sample sizes. Statistical power calculations of the AD and AB groups are presented in Supporting Information Table S4 . We therefore limited the analysis of IQ and deletion type to the AD and AB groups. Compared with males, the full scale and performance IQ scores in females with 22q11.2DS with the AD and AB deletions were 1-2 points higher (Figure 2 , full scale IQ was 71.7 AE 14.2 and performance IQ was 72.0 AE 14.1; full scale IQ was 73.1 AE 13.2 and performance IQ was 73.9 AE 13.3 for males and females, respectively). These differences in both full scale and performance IQ scores, but not in verbal IQ, between males and females were significant p < .05, despite their small effect sizes (Figure 2 ).
The age distribution in both the AD and AB groups were shifted toward having more than 50% of patients with an age between 6 and 20 years old and less than 50% with an age between 21 and 66 years (Supporting Information Figure S3 , both p < .05 for the one-sample Kolmogorov-Smirnov test for normality). However, the age distribution was not significantly different between the AD and AB groups (asymptotic p > .05 for independent-samples MannWhitney U test). Moreover, no significant differences were observed for median ages between the two groups (age = 12.67 AE 9.67 and 13.08 AE 11.54 for AD and AB groups, respectively) according to the independent-samples non-parametric Median Test, as shown in Supporting Information Figure S3 . We also evaluated the distributions of categorical variables between AD and AB groups (Supporting Information Table S5 ). As is shown, the distribution of sex, CHD status, IQ test types, and study sites are not significant (all p > .05). 3.4 | IQ score distribution in subjects with severe CHD as compared to those with a normal heart or aortic arch Individuals in the general population with severe CHD that require surgery for survival, may have increased risk for neurodevelopmental deficits as measured, in part, by the presence of lower IQ scores (Latal, 2016; Marino et al., 2012) . The prevalence of severe CHD in our cohort is shown in Table 1 . There was no significant difference between the prevalence of severe CHD in the AD (32.5%, 593 controls versus 286 severe CHD cases) or AB (36.2% 30 controls versus 17 severe CHD cases, asymptotic p > .05) using the Pearson chi-square test. We found a decrease of <1 point in full scale IQ, verbal IQ, and performance IQ in 22q11.2 subjects with severe CHD compared with 22q11.2 subjects with no detectable cardiac or aortic arch defects (Figure 3) . These differences were not significant (all three p > .05).
| IQ distribution among 22q11.2DS patients with AB and AD deletion types
We found that full scale IQ, verbal IQ, and performance IQ scores increased by 0.3-0.5 SD in the AB group compared to the AD group as shown in Figure 4 . We then conducted multiple linear regression analyses between IQ and deletion type with an adjustment of age, gender, and collection site (Table 2) . We found an increase of 5.64, 7.06, and 4.42 points for full scale IQ, verbal IQ, and performance IQ, respectively, all p < .05. Adjusted R square/variance for full scale IQ, verbal IQ, and performance IQ was 0.047, 0.037, and 0.05, respectively. Thus, while the presence of a deletion confers the highest influence on IQ, subjects with the smaller AB deletion were relatively less affected than those with the typical, larger AD deletion. Taking USA and Canada as a reference, significantly lower IQ scores were observed for Northern Europe. Variances detected may reflect differences in health care structure/availability and/or education system. .91 AE 14.5), and performance IQ (PIQ, 73.01 AE 13.7) among the 22q11.2DS population and fitted normal curves to the right, respectively. The normal curves to the left denote the IQ distribution in general population (100 AE15). Distribution of IQ are shifted to the left as compared to those in general population by almost 2 SDs. (d) Differences of mean IQ scores were determined by independent samples t test. **p < .01. Numbers in the bars denote the samples with FSIQ, VIQ, and PIQ, available, respectively. FSIQ, VIQ, and PIQ were all significantly lower than those of general population
To check this further, we ran a stratified multivariable linear regression analysis of IQ and deletion size with adjustment of sex and age for each research site, respectively (Supporting Information Table S3 ).
Although the differences of IQ between AD and AB are not always significant for each of the 21 research sites, the direction of beta were consistent across the different groups.
| DISCUSSION
In this report, we examined IQ scores in a large cohort of 1,478 subjects with 22q11.2DS, obtained predominantly as part of the International 22q11.2 Brain and Behavior Consortium (Gur et al., 2017) .
Previously, it has been shown that verbal IQ scores are 6-8 points higher than performance IQ scores in individuals with 22q11.2DS (Antshel, Kates, Roizen, Fremont, & Shprintzen, 2005; De Smedt et al., 2007; Moss et al., 1999; Swillen et al., 1997) . In this large cohort, we found that verbal IQ scores were only 3 points higher than performance IQ scores. Some previous reported data showed there was a small increase of IQ in females versus males, although in other studies, there was no increase found (Antshel et al., 2005; De Smedt et al., 2007; Klaassen et al., 2016; Moss et al., 1999; Niklasson & Gillberg, 2010; Van Aken et al., 2007) . In this cohort, we found that full scale and performance IQ were only 1-2 points higher in females but this small difference was statistically significant. While a significant difference (p = .017) in age distribution between males (15.03 AE 9.20) and females (16.78 AE 10.43) was observed, the effect of gender on IQ may be slightly biased by this difference in age distribution. We found that among the different research sites for this study, our data was consistent with the finding that those with the AD deletion had a lower IQ than those with the AB deletion.
There is a consideration that individuals that inherit a 22q11.2 deletion tend to have a lower IQ than those with a de novo deletion (Driscoll, Budarf, & Emanuel, 1992; Lindsay et al., 1995; Morrow et al., 1995) . One limitation of our study is that we have not yet obtained information on the parental deletion status or education level. We are currently in the process of getting such information for the cohort presented here, but
as of yet it is quite incomplete.
FIGURE 2 IQ distribution between males and females within the 22q11.2DS population. IQ values are expressed as mean AE SD. An independent-samples t test was conducted to compare the mean IQ scores in male versus female subjects. Significant differences are denoted by an asterisk in bar plots with p < .05. Numbers in the bars denote samples size of each category FIGURE 3 Full scale, verbal, and performance IQ distribution between cases with severe CHD and control subjects with no CHD within the 22q11.2DS population. Severe CHD is defined as subjects with either tetralogy of Fallot, persistent truncus arteriosus or interrupted aortic arch type B. Control subjects for CHD cases had 22q11.2DS but no detectable heart or aortic arch defect. IQ values were expressed as mean AE SD. An independent-samples t test was conducted to compare IQ scores in subjects with the presence of severe CHD and controls within the 22q11.2DS cohort. All p values were > .05. Numbers in the bars denote the sample size of each category FIGURE 4 IQ score differences between AD and AB deletion types in subjects with 22q11.2DS. IQ values were expressed as mean AE SD. An independent-samples t test was conducted to compare mean IQ scores in subjects carrying the AB deletion with those carrying the AD deletion. ***p < .001, **p < .01, *p < .05. Numbers in the shaded bars denote the samples size in each category. Full scale IQ, verbal IQ, and performance IQ decreased by 0.3-0.5 SD among those in the AD group as compared with those in the AB group It is well established using longitudinal studies (Duijff et al., 2012; Gothelf, Penniman, Gu, Eliez, & Reiss, 2007b ) and supported by crosssectional studies (Antshel et al., 2010; Duijff et al., 2012; Golding-Kushner, Weller, & Shprintzen, 1985; Gothelf, Aviram-Goldring, et al., 2007a; Gothelf et al., 2005; Niklasson & Gillberg, 2010; Shprintzen, 2000) that individuals with 22q11.2DS show decline in IQ scores, referred to as cognitive decline. In the largest study to date of 829 subjects with 22q11.2DS, ages 8-24 years, cognitive decline was quite notable. There was a reported decline of full scale IQ of 7.04 points, verbal IQ of 9.02 points and performance IQ of 5.09 points . We checked whether there was a bias of age between subjects in the AB group versus those with the AD group, and we did not find a significant difference. However, we are aware that our analysis has limitations in that the IQ scores represent summaries of cognitive abilities and may not reflect with the complete picture of possible cognitive differences between the deletion size cohorts.
CHD that requires surgery to repair were reported to be associated with neurodevelopmental deficits (Latal, 2016; Marino et al., 2012) . In this report, we tested whether 22q11.2DS individuals with severe CHD that usually required surgical repair (TOF, PTA, and IAAB; all complex cardiac outflow tract anomalies) had lower IQ scores.
However, we did not find a correlation between severe CHD and altered IQ values for our cohort of 22q11.2DS subjects, suggesting that different mechanisms contribute to severe CHD and to cognition as measured by IQ tests in this 22q11.2DS group. Further, it suggests that surgical intervention to correct cardiac malformations do not further impair the IQ.
The phenotypic spectrum of 22q11.2DS is quite wide and vari- There are 30 known protein-coding genes that span the AB region on 22q11.2 (Supporting Information Figure S4 ). Many are implicated in brain development or function (Maynard et al., 2003; Meechan et al., 2015) . Coding genes implicated in cognitive and/or neuropsychiatric findings include TBX1 (Cioffi et al., 2014; Hiroi, Hiramoto, Harper, Suzuki, & Boku, 2012) , COMT, encoding catechol-O-methyltansferase (Dickinson & Elvevag, 2009; Guo et al., 2017; Radoeva et al., 2014; Vorstman et al., 2015) , PRODH, encoding proline oxidase (Guo et al., 2017; Radoeva et al., 2014) , and DGCR8, encoding an enzyme for miRNA processing (Forstner, Degenhardt, Schratt, & Nothen, 2013 ) among many others (Karayiorgou, Simon, & Gogos, 2010; Meechan et al., 2015) . Thus, it is likely that haploinsufficiency of one or more of these genes is important for IQ and cognition in the AB region.
Upon examination of the literature, individuals with a BD or nested CD deletion have been identified with developmental delay and/or cognitive impairment (Rump et al., 2014) . Among a set of 46 subjects combined with the literature, 9 of 17 individuals with a BD deletion (53%) and 16 of 29 with a CD deletion (55%) were affected with developmental delay and cognitive impairment (Rump et al., 2014) . These data suggest that important genes may lie within the nested CD region. Among the nine coding genes in the CD region, SNAP29 (synaptosome associated protein 29, and CRKL (CRK like proto-oncogene, adaptor protein) are of particular interest. SNAP29 encodes a protein required for intracellular trafficking and homozygous inactivating mutations cause a rare disorder termed CEDNIK syndrome, associated with cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma (Sprecher et al., 2005) 
| CONCLUSIONS
In this report, we compared the AD versus AB deletion type in a large cohort of subjects with 22q11.2DS to determine if there is a difference in IQ levels. Here we found that over and beyond the overall effect of having a 22q11.2 deletion, those with the larger, 3 Mb AD deletion have slightly lower IQ scores than those with the nested, 1.5 Mb AB deletion.
Our results indicate that while genes in the AB region are critically important, genes within the distal BD region may exert an additional contribution to the overall cognitive phenotype in these patients. This is consistent with findings in the literature that patients with the nonoverlapping BD or CD deletion also have cognitive impairment.
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